Industry and Exhibits - Corporate Activities Program
CAP is a membership program committed to helping the world’s population lead healthier lives through advances in health care and the education of future physicians, scientists, and researchers. CAP contributions support undergraduate or predoctoral students, Ph.D.s and M.D.s who are presenting abstracts at ASM's annual ICAAC or General Meeting.
Membership in CAP provides increased corporate visibility with ASM's 44,000 scientific and physician members and meeting delegates. Members receive corporate recognition within the microbiological and infectious diseases communities at the General Meeting, ICAAC, Biodefense Research Meeting and throughout the year. CAP furthers the efforts of product/marketing, scientific/education, exhibit, human resource, and press directors through positive publicity.
The ASM Corporate Activities Program (CAP) is comprised of the leaders in the scientific and pharmaceutical industries who help the world’s population lead healthier lives through advances in health care. They are ASM most valued colleagues in the advancement of the Society’s mission to support education and special initiatives on unmet medical needs in areas such as antimicrobial resistance, HIV/ AIDS, multidrug-resistant Staphylococcus aureus, and others. CAP provides travel grants for students or postdoctoral fellows to present abstracts at either the General Meeting or ICAAC. Many CAP members also contribute to ASM’s meetings, conferences, programs, and awards through individual grants and sponsorships.
The CAP logo (the ASM microscope and the year of CAP participation) identifies CAP corporations in various ASM publications. At the General Meeting and ICAAC, badge ribbons will identify the staff of CAP companies. ASM members and colleagues are encouraged to visit the CAP participants’ web pages or booths at the General Meeting exhibits to learn more about the companies that generously support ASM and its educational goals.
ASM would like to acknowledge the CAP partners supporting educational activities at the 108th General Meeting: Advanced Life Sciences, for an ASM CME-accredited satellite symposium; Boehringer Ingelheim Pharmaceuticals, Inc., for the HIV-Drug Resistance Initiative and ASM CME-accredited satellite symposium; and Wyeth for the ID Fellows Grant Program.
2008 Corporate Activities Program Members (as of 24 March 2008)
There are two levels of participation: Corporate Partner, the higher level and Corporate Sponsor.
CAP Corporate Partners
- Advanced Life Sciences
- bioMérieux, Inc.
- Boehringer Ingelheim Pharmaceuticals, Inc.
- Gilead Sciences, Inc.
- GlaxoSmithKline Pharmaceuticals
- Merck & Co., Inc.
- Pfizer Inc.
- Roche
- Schering-Plough
- Targanta Therapeutics
- Wyeth
CAP Corporate Sponsors
- New Brunswick Scientific Co., Inc.
To view more information about ASM's CAP Program, go here.